Pradeep Deshmukh

Pradeep Deshmukh

Active Director Director DIN 06834920
DIN 06834920 First appointment Mar 2014 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2014
Shareholding value •••• Premium profile

About Pradeep Deshmukh

Data last updated:

Pradeep Deshmukh is a Director at Treathealth Pharmaceuticals Private Limited (since 2014). The company operates in Pharma. Treathealth Pharmaceuticals Private Limited reported revenue of ₹17 Lakh (FY 2025).

DIN 06834920
Primary Designation Director
Industry Pharma
First Appointment 24 Mar 2014
Oldest Company Age 12 yrs
Largest company Treathealth Pharmaceuticals Private Limited · ₹17 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director24 Mar 20142014₹17 Lakh (FY 2025)Active

Board colleagues of Pradeep Deshmukh

Directorship timeline

Open interactive timeline →
Treathealth Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Pradeep Deshmukh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pradeep Deshmukh

Pradeep Deshmukh currently holds 1 directorship: Treathealth Pharmaceuticals Private Limited (Director, since 24 Mar 2014, revenue ₹17 Lakh (FY 2025)).

Pradeep Deshmukh was first appointed on 24 Mar 2014 as Director at Treathealth Pharmaceuticals Private Limited.

The current boards of Pradeep Deshmukh's companies include Sheetal Pradeep Deshmukh (Treathealth Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available